Thomas Leclerc

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

P. Jault, Thomas Leclerc, Serge Jennes et al. · The Lancet Infectious Diseases · 2018 · 802 citations · Full text

Wound Care, Burn Management, Pseudomonas Aeruginosa +8

Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources

Thomas Leclerc, Nicolas Donat, Alexis Donat et al. · Anaesthesia Critical Care & Pain Medicine · 2020 · 79 citations · Full text

Critical Care Management, Ill Patients, Icu Treatments +6

Recommendations for burns care in mass casualty incidents: WHO Emergency Medical Teams Technical Working Group on Burns (WHO TWGB) 2017-2020

Amy Hughes, Stian Kreken Almeland, Thomas Leclerc et al. · Burns · 2020 · 78 citations · Full text

Emergency Management, Injury Prevention, Burns +26

Cultured epithelial autografts in massive burns: A single-center retrospective study with 63 patients

A. Cirodde, Thomas Leclerc, P. Jault et al. · Burns · 2011 · 61 citations

Regenerative Medicine, Cultured Epithelial Autografts, Pathology +8

Epidemiology of filamentous fungal infections in burned patients: A French retrospective study

Jean-Vivien Schaal, Thomas Leclerc, C. Soler et al. · Burns · 2015 · 58 citations

French Retrospective Study, Burns, Burn Management +6